124 related articles for article (PubMed ID: 17804074)
1. New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents.
Urquiola C; Gambino D; Cabrera M; Lavaggi ML; Cerecetto H; González M; de Cerain AL; Monge A; Costa-Filho AJ; Torre MH
J Inorg Biochem; 2008 Jan; 102(1):119-26. PubMed ID: 17804074
[TBL] [Abstract][Full Text] [Related]
2. Novel Cu(II) quinoxaline N1,N4-dioxide complexes as selective hypoxic cytotoxins.
Torre MH; Gambino D; Araujo J; Cerecetto H; González M; Lavaggi ML; Azqueta A; López de Cerain A; Vega AM; Abram U; Costa-Filho AJ
Eur J Med Chem; 2005 May; 40(5):473-80. PubMed ID: 15893021
[TBL] [Abstract][Full Text] [Related]
3. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.
Vieites M; Noblía P; Torre MH; Cerecetto H; Laura Lavaggi M; Costa-Filho AJ; Azqueta A; de Cerain AL; Monge A; Parajón-Costa B; González M; Gambino D
J Inorg Biochem; 2006 Aug; 100(8):1358-67. PubMed ID: 16698084
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs.
Urquiola C; Vieites M; Torre MH; Cabrera M; Lavaggi ML; Cerecetto H; González M; Cerain AL; Monge A; Smircich P; Garat B; Gambino D
Bioorg Med Chem; 2009 Feb; 17(4):1623-9. PubMed ID: 19162490
[TBL] [Abstract][Full Text] [Related]
5. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
Buravchenko GI; Scherbakov AM; Dezhenkova LG; Bykov EE; Solovieva SE; Korlukov AA; Sorokin DV; Monzote Fidalgo L; Shchekotikhin AE
Bioorg Chem; 2020 Nov; 104():104324. PubMed ID: 33142432
[TBL] [Abstract][Full Text] [Related]
6. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
Noblía P; Vieites M; Torre MH; Costa-Filho AJ; Cerecetto H; González M; Lavaggi ML; Adachi Y; Sakurai H; Gambino D
J Inorg Biochem; 2006 Feb; 100(2):281-7. PubMed ID: 16386797
[TBL] [Abstract][Full Text] [Related]
7. Improving anti-trypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide derivatives by complexation with vanadium.
Urquiola C; Vieites M; Aguirre G; Marín A; Solano B; Arrambide G; Noblía P; Lavaggi ML; Torre MH; González M; Monge A; Gambino D; Cerecetto H
Bioorg Med Chem; 2006 Aug; 14(16):5503-9. PubMed ID: 16709457
[TBL] [Abstract][Full Text] [Related]
8. Revision of the Regioselectivity of the Beirut Reaction of Monosubstituted Benzofuroxans with Benzoylacetonitrile. 6-Substituted quinoxaline-2-carbonitrile 1,4- dioxides: Structural Characterization and Estimation of Anticancer Activity and Hypoxia Selectivity.
Buravchenko GI; Scherbakov AM; Korlukov AА; Dorovatovskii PV; Shchekotikhin AE
Curr Org Synth; 2020; 17(1):29-39. PubMed ID: 32103715
[TBL] [Abstract][Full Text] [Related]
9. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part III.
Cerecetto H; González M; Risso M; Saenz P; Olea-Azar C; Bruno AM; Azqueta A; De Ceráin AL; Monge A
Arch Pharm (Weinheim); 2004 May; 337(5):271-80. PubMed ID: 15095420
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 3-aryl-quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives as hypoxic selective anti-tumor agents.
Hu Y; Xia Q; Shangguan S; Liu X; Hu Y; Sheng R
Molecules; 2012 Aug; 17(8):9683-96. PubMed ID: 22890172
[TBL] [Abstract][Full Text] [Related]
11. Syntheses and spectroscopic studies of potential antitumor copper(II) complexes with 5-phenylazo-3-methoxy salicylidene thiosemicarbazone and N4 substituted thiosemicarbazones.
Patil BG; Havinale BR; Shallom JM; Chitnis MP
J Inorg Biochem; 1989 Jun; 36(2):107-13. PubMed ID: 2547893
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides.
Monge A; Palop JA; López de Ceráin A; Senador V; Martínez-Crespo FJ; Sainz Y; Narro S; García E; de Miguel C; González M
J Med Chem; 1995 May; 38(10):1786-92. PubMed ID: 7752202
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, crystal structure, cytotoxic and superoxide dismutase activities of copper(II) complexes of N-(4,5-dihydroimidazol-2-yl)azoles.
Saczewski F; Dziemidowicz-Borys E; Bednarski PJ; Gdaniec M
Arch Pharm (Weinheim); 2007 Jul; 340(7):333-8. PubMed ID: 17611942
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure and biomimetic properties of Cu(II)-Cu(II) and Cu(II)-Zn(II) binuclear complexes: possible models for the chemistry of Cu-Zn superoxide dismutase.
Patel RN; Singh N; Shukla KK; Gundla VL; Chauhan UK
J Inorg Biochem; 2005 Feb; 99(2):651-63. PubMed ID: 15621300
[TBL] [Abstract][Full Text] [Related]
15. Macrocyclic copper(II) complexes: superoxide scavenging activity, structural studies and cytotoxicity evaluation.
Fernandes AS; Gaspar J; Cabral MF; Caneiras C; Guedes R; Rueff J; Castro M; Costa J; Oliveira NG
J Inorg Biochem; 2007 May; 101(5):849-58. PubMed ID: 17376531
[TBL] [Abstract][Full Text] [Related]
16. New quinoxalinecarbonitrile 1,4-di-N-oxide derivatives as hypoxic-cytotoxic agents.
Ortega MA; Morancho MJ; Martínez-Crespo FJ; Sainz Y; Montoya ME; López de Ceráin A; Monge A
Eur J Med Chem; 2000 Jan; 35(1):21-30. PubMed ID: 10733600
[TBL] [Abstract][Full Text] [Related]
17. An efficient synthesis of quinoxaline derivatives from 4-chloro-4-deoxy-alpha-D-galactose and their cytotoxic activities.
Yan L; Liu FW; Dai GF; Liu HM
Bioorg Med Chem Lett; 2007 Feb; 17(3):609-12. PubMed ID: 17110108
[TBL] [Abstract][Full Text] [Related]
18. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA
Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668
[TBL] [Abstract][Full Text] [Related]
19. Spectroscopic characterization of copper(II) complexes of indoxyl N(4)-methyl thiosemicarbazone.
Chandra S; Kumar U
Spectrochim Acta A Mol Biomol Spectrosc; 2004 Oct; 60(12):2825-9. PubMed ID: 15350918
[TBL] [Abstract][Full Text] [Related]
20. Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells.
Balakrishna MS; Suresh D; Rai A; Mague JT; Panda D
Inorg Chem; 2010 Oct; 49(19):8790-801. PubMed ID: 20812680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
